Value Added Services 2.0: From sales tactics to commercial strategy
Oct 8, 2014
Soeren Mattke, Senior Scientist at RAND, describes how changing environments force Pharma to rethink its traditional business model, how those who miss out on the opportunity created by value-based payment models will suffer badly, and why the increasing sophistication of technology is making value-based commercial models viable.
This content is premium content, and only accessible to Premium members. Get On Demand now